Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.32 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.32 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.31 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.31 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.30 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.30 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.30 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.30 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24384355 | 0.73 | ALDH1A1 (0.52) | ALDH1A1TDP1TSHRFFAR1HDAC8 | |
| SCHEMBL2430307 | 0.73 | ALDH1A1 (0.59) | ALDH1A1TSHRFFAR1 | |
| SCHEMBL15943546 | 0.73 | FFAR1 (0.40) | FFAR1 | |
| SCHEMBL6514299 | 0.70 | ALDH1A1 (0.48) | ALDH1A1TDP1TSHRFFAR1HDAC8 | |
| Hydrogen Peroxide SCHEMBL28624206 | 0.69 | ALDH1A1 (0.85) | ALDH1A1TDP1TSHRHDAC8TAS1R3 | |
| SCHEMBL7639 | 0.69 | ALDH1A1 (1.00) | ALDH1A1TDP1TSHRHDAC8TAS1R3 | |
| SCHEMBL473081 | 0.69 | ALDH1A1 (1.00) | ALDH1A1TDP1TSHRHDAC8TAS1R3 | |
| SCHEMBL8767071 | 0.69 | ALDH1A1 (0.61) | ALDH1A1TDP1TSHRHDAC8CHRNB2 | |
| SCHEMBL436135 | 0.68 | ALDH1A1 (0.46) | ALDH1A1TDP1TSHRHDAC8CHRNB2 | |
| SCHEMBL22722365 | 0.68 | ALDH1A1 (0.46) | ALDH1A1TDP1TSHRHDAC8CHRNB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230314934-A1 | PHOTOACTIVE COMPOUNDS, PHOTORESIST COMPOSITIONS INCLUDING THE SAME, AND PATTERN FORMATION METHODS | U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS NOTES COLLATERAL AGENT | 2023-10-05 | — | — | US | disclosed |
| US-20230314934-A1 | PHOTOACTIVE COMPOUNDS, PHOTORESIST COMPOSITIONS INCLUDING THE SAME, AND PATTERN FORMATION METHODS | U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS NOTES COLLATERAL AGENT | 2023-10-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230314934-A1 | PHOTOACTIVE COMPOUNDS, PHOTORESIST COMPOSITIONS INCLUDING THE SAME, AND PATTERN FORMATION METHODS | CRY1, CBR3, C1S | ALDH1A1 810/4885TDP1 4644/4885TSHR 1483/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.